An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence

Abstract

Recent introduction of rapid bromelain-based enzymatic debridement has been increasingly popular in its use in nonsurgical debridement in deep partial and full thickness burns. We designed this study to evaluate the evidence suggested by current studies on the perceived benefits of using Nexobrid® compared with traditional surgical standard of care in burns wound debridement. A comprehensive search on electronic databases Pubmed, Embase, and Web of Science was done to identify studies published between 1986 and 2017 involving the use of Nexobrid® in deep partial and full thickness burns. Studies were evaluated for proposed benefits and categorized under supporting evidence, contradicting evidence, and anecdotal opinions. Seven well-designed prospective studies met the inclusion comprising four randomized controlled trials. Six proposed benefits associated with the use of Nexobrid® were extracted including reduced time to complete debridement, need for surgery, area of burns excised, need for autograft, time to wound closure, and improved scar quality. Most proposed benefits have strong supporting evidences with minimal anecdotal opinions from controlled trials except the proposed improvement in scar quality and reduced time to wound healing that had at least three refuting evidence and one anecdotal evidence. Incidence of pain was also evaluated and was mainly anecdotal lacking formal objective assessment or cohort study. Despite the lack of literatures available, the benefits of Nexobrid® are evident in published randomized and single arm studies. Large number of studies is needed to aid further evaluating the proposed benefits of Nexobrid®.

Indeterminate-Depth Burn Injury—Exploring the Uncertainty

“…More RCTs are needed to establish its efficacy and feasibility before it is broadly accepted. 52,55 Collagenase Collagenase ointment generally refers to a collagenase proteolytic mixture derived from Clostridium histolyticum, although collagenase mixtures derived from other bacterial sources such as Streptomyces also exist. 56,57 Because collagenase is specific to collagen, a protein comprising up to 75% of the dermis, it is considered a "selective" debriding agent.…”

State of the art in enzymatic debridement

“…Despite the growing experience, the literature offers seven publications on studies with a high level of evidence proving ED' s advantages with certain issues over standard of care (SOC), which is remarkable for literature in burns. Loo et al [16] investigated literature on ED from 1986 to 2017 and reported seven prospective studies including four randomized controlled trials in a recent review. The largest available randomized-control trial by Rosenberg et al [5] compared 74 cases of ED with 81 cases treated by SOC and could show a significant shorter time to complete eschar removal, a lower number of wounds requiring surgical excision and STSG as well as a significant lower blood loss in in the ED group.…”

A Critical Update of the Assessment and Acute Management of Patients with Severe Burns

“…It is associated with a reduced time to complete debridement, reduced need for surgery, reduced area of burns excised, and reduced need for autografting. 179 Chemical debridement is far less painful than sharp debridement, so a general anesthetic is usually avoided. However, its use is associated with procedural pain therefore local or regional anesthesia and/or pre-emptive analgesia are required.…”